BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 4, 2004
View Archived Issues
Spotlight on glycogen synthase kinase-3
Read More
New platelet antiaggregatory agents discovered at Toray
Read More
A novel IKK-2 inhibitor and its use reported by GSK researchers
Read More
New cinnoline-based antitumor agents in early development at Nippon Kayaku
Read More
Tetrahydroquinoline-based antiinflammatory agents prepared and tested at Kyowa Hakko
Read More
Novel PI3K inhibitors and their use in rheumatoid arthritis and other disorders
Read More
New tubulin polymerization inhibitors covered by Cytopia patent
Read More
New antibacterial agents under evaluation at GeneSoft
Read More
CV Therapeutics and FDA agree to SPA for Ranexa
Read More
FTC clears Sanofi-Synthelabo's offer for Aventis
Read More
Prima BioMed initiates phase II study in ovarian cancer
Read More
Orally active agent against respiratory syncytial virus
Read More
Neuroprotective microtubule polymerizing agent set for clinical development
Read More
Synthetic indole compound effective against multidrug resistant tumors in vivo
Read More
Evotec OAI and ActivBiotics establish joint drug discovery project
Read More
Structural GenomiX acquires Troxatyl rights
Read More
Good efficacy and safety shown for long-term use of Sanctura
Read More
Orphan drug status for PYM-50018 for ALS
Read More
R-112 reduces symptoms of allergic rhinitis in phase II study
Read More
mondoBIOTECH and Bachem sign aviptadil agreement
Read More
Antituberculosis agent shows promising effects in pilot trial
Read More
OSI completes Tarceva NDA filing in NSCLC
Read More
Accelerated approval for Truvada
Read More
Lipitor approved to reduce risk of heart attacks
Read More
Epzicom receives FDA approval
Read More
Abbott submits NDA for Zemplar capsules
Read More
YM-348 reduces food intake, body weight gain in obesity model
Read More